Understanding how certain brain cells develop and connect in relation to mental health disorders
Molecular Development and Diversity of Callosal Projection Neurons
This study is looking at how certain brain cells that help connect the two sides of the brain develop and work, which could help us understand and find new treatments for mental health issues like autism and schizophrenia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10794934 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that control the development and diversity of callosal projection neurons (CPNs), which are crucial for connecting the two hemispheres of the brain. By examining how these neurons form and connect, the research aims to uncover potential causes of various mental health disorders, such as autism and schizophrenia. The study employs innovative genetic and molecular techniques to explore the specific subtypes of CPNs and their connectivity patterns. This could lead to new therapeutic approaches for disorders linked to CPN dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autism spectrum disorders, schizophrenia, or other related mental health conditions.
Not a fit: Patients with mental health disorders not related to CPN dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights into the underlying causes of mental health disorders and pave the way for new treatment strategies.
How similar studies have performed: Other research has shown success in understanding neuronal connectivity and its implications for mental health, making this approach promising.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Macklis, Jeffrey D — Harvard University
- Study coordinator: Macklis, Jeffrey D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.